alt Hacker News"We shouldn't collect information because we don't know how to fit it into our care playbook" might be rational for a single patient, but it's a policy that will lock you into your current playbook.
Our medical industry is set up to only evolve via highly centralized research that fully situates a diagnostic within a particular treatment path. This approach makes it more and more expensive to improve care for narrower and narrower populations - driving medicine towards being a luxury good.
I'd like to see midjourney say more about price, but I love the idea of starting some new diagnostic pathways with different principles. There are probably all sorts of low hanging fruit to be found about new treatment strategies... It just takes some faith that nature hasn't hidden all of her secrets in the one place we already know how to look.
I understand your point, and I might even agree to some extent. However, the issue is that this isn't presented as an opportunity to do research, but as commoditizing a clinical test that, when it isn't done for medical reasons (i.e., investigating some existing symptoms), can lead to a lot of false positives.